About Yst Life Sciences Private Limited
Data last updated:
Yst Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 20 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC292660. Its GSTIN is 27AAACY8755H1ZU (Maharashtra).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.53 Cr. It is led by directors Yash Sunil Tikekar and Vasant Raghunath Tikekar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.37 Cr, a growth of 94% compared to the previous year. For the same year it recorded a net profit of ₹1.64 Cr (net margin 6.7%) and EBITDA of ₹3.53 Cr (EBITDA margin 14.5%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years.
As per MCA filings, the company has open charges of ₹40.5 Cr and satisfied charges of ₹2.5 Cr on record. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in March 2020.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ystlifesciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop 206 Floor – 2 Sumer Kendra Shivram Seth Amrutwar Road, Near Doordarshan Kendra Off Pandurang Budhwar Marg Worli, Mumbai, Maharashtra, India – 400018
- IndustryChemicals and Materials, Specialty Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Yst Life Sciences Private Limited
The main business activity of Yst Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Yst Life Sciences Private Limited FY 2024 filings available
Yst Life Sciences Private Limited reported revenue of ₹24.37 Cr (up 94% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Yst Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 50% over three years, including 94% growth in the latest year. EBITDA rose 489% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Yst Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.53 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.64 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Yst Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Yst Life Sciences are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Yst Life Sciences Private Limited
Yst Life Sciences Private Limited is audited by R TRIVEDI & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R TRIVEDI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Yst Life Sciences Private Limited
Yst Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yash Sunil Tikekar Also directs: Indian Emulsifiers Limited, Yst Surfactants Private Limited, VRT Enterprises Private Limited and 2 more | Director | 20 Mar 2017 | 9 Years 6 Months | Current |
| Vasant Raghunath Tikekar | Director | 11 Mar 2019 | 7 Years 6 Months | Current |
Ownership and Shareholding of Yst Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Yst Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2025 | Others | ₹2.5 Cr | Open |
| 14 Feb 2025 | Uco Bank | ₹15 Cr | Open |
| 03 Oct 2023 | Others | ₹20 Cr | Open |
| 03 Oct 2023 | Others | ₹3 Cr | Open |
| 16 Feb 2021 | Canara Bank | ₹2.5 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of Yst Life Sciences Private Limited
Yst Life Sciences Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in March 2020.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Rights issue | ₹1 Cr | Investors: VRT Enterprises Private Limited , an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Yst Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Yst Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Yst Life Sciences Private Limited
Yst Life Sciences Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Alpesh Arvindlal Gandhi ceased to be Additional Director on 01 Jan 2024.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Yst Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Yst Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Yst Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Yst Life Sciences Private Limited
Yst Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACY8755H1ZU | Maharashtra | Active | 12 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Yst Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yst Life Sciences Private Limited
Yst Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 20 March 2017 (9+ years old) and is registered under CIN U24304MH2017PTC292660.
Yst Life Sciences reported revenue of ₹24.37 Cr for FY 2024 (up 94% YoY).
Yst Life Sciences has 2 current directors:
- Yash Sunil Tikekar - Director
- Vasant Raghunath Tikekar - Director
Yst Life Sciences reported a net profit of ₹1.64 Cr (net margin 6.7%) and EBITDA of ₹3.53 Cr (EBITDA margin 14.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Yst Life Sciences is 50% over three years. In the latest year (FY 2024) revenue rose 94%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Yst Life Sciences is 27AAACY8755H1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Yst Life Sciences is U24304MH2017PTC292660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yst Life Sciences was incorporated on 20 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Yst Life Sciences has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in March 2020.
Alpesh Arvindlal Gandhi ceased to be Additional Director on 01 Jan 2024. Mahesh Ambalal Modi ceased to be Additional Director on 01 Jan 2024. Mrugesh Alpesh Gandhi ceased to be Additional Director on 01 Jan 2024. Yst Life Sciences has 6 board changes on record in total.